Hasselström J, Säwe J
Department of Clinical Pharmacology, Huddinge University Hospital, Karolinska Institute, Sweden.
Clin Pharmacokinet. 1993 Apr;24(4):344-54. doi: 10.2165/00003088-199324040-00007.
Morphine, morphine-6-glucuronide (M6G), morphine-3-glucuronide (M3G) and normorphine were analysed with high performance liquid chromatography in plasma and urine, collected over 72 h after administration of single intravenous 5 mg and oral 20 mg doses of morphine to 7 healthy volunteers. Systemic plasma clearance of morphine was on average 21.1 +/- 3.4 ml/min/kg (1.27 +/- 0.20 L/h/kg), volume of distribution was 2.9 +/- 0.8 L/kg and oral bioavailability was 29.2 +/- 7.2%. Clearance of morphine to form M3G and M6G comprised 57.3% and 10.4%, respectively, and renal clearance comprised 10.9% of total systemic plasma clearance; hence, more than one-fifth of a dose (20.8%) remained as unidentified residual clearance. On the basis of the area under the plasma concentration-time curves determined after oral and intravenous administration, the ratios of M6G:morphine were 3.6 +/- 1.2 and 0.7 +/- 0.3, respectively. The corresponding figures for M3G:morphine were 29.9 +/- 6.8 and 7.7 +/- 1.4. Differences in metabolic ratios between the parenteral and oral routes could be attributed solely to differences in morphine concentrations as evidenced both by plasma concentrations and amounts excreted in urine. An oral:parenteral potency ratio of 1:3 may, thus, be due to differences in circulating amounts of morphine since the proportions of an administered dose found as M6G and M3G after administration by both routes were equal. A major finding was a slowly declining terminal phase of morphine and metabolites that was evident both in plasma and in urinary excretion versus time curves, where the half-lives of morphine, M3G and M6G were 15.1 +/- 6.5 h, 11.2 +/- 2.7 h and 12.9 +/- 4.5 h, respectively. The terminal half-life of normorphine was 23.9 +/- 10.1 h after oral administration. Comparison of oral with intravenous excretion curves showed that a greater part of morphine and metabolites were excreted during the slowly declining phase after the oral dose than the intravenous dose, which is highly suggestive of enterohepatic cycling. The renal clearance of M6G and morphine was seen to exceed creatinine clearance, possibly due to an active secretion process.
对7名健康志愿者单次静脉注射5毫克和口服20毫克吗啡后72小时内采集的血浆和尿液,采用高效液相色谱法分析吗啡、吗啡 - 6 - 葡萄糖醛酸苷(M6G)、吗啡 - 3 - 葡萄糖醛酸苷(M3G)和去甲吗啡。吗啡的全身血浆清除率平均为21.1±3.4毫升/分钟/千克(1.27±0.20升/小时/千克),分布容积为2.9±0.8升/千克,口服生物利用度为29.2±7.2%。吗啡转化为M3G和M6G的清除率分别占57.3%和10.4%,肾清除率占全身血浆总清除率的10.9%;因此,超过五分之一的剂量(20.8%)仍为未明确的残余清除率。根据口服和静脉给药后测定的血浆浓度 - 时间曲线下面积,M6G与吗啡的比值分别为3.6±1.2和0.7±0.3。M3G与吗啡的相应数值分别为29.9±6.8和7.7±1.4。肠外和口服途径代谢比值的差异可能仅归因于吗啡浓度的差异,血浆浓度和尿中排泄量均证明了这一点。因此,口服与肠外效价比为1:3可能是由于吗啡循环量的差异,因为两种途径给药后作为M6G和M3G发现的给药剂量比例是相等的。一个主要发现是吗啡及其代谢物的终末相下降缓慢,这在血浆和尿排泄量与时间曲线中均很明显,其中吗啡、M3G和M6G的半衰期分别为15.1±6.5小时、11.2±2.7小时和12.9±4.5小时。口服后去甲吗啡的终末半衰期为23.9±10.1小时。口服与静脉排泄曲线的比较表明,口服给药后,在缓慢下降阶段排泄的吗啡及其代谢物比静脉给药更多,这强烈提示存在肠肝循环。M6G和吗啡的肾清除率超过肌酐清除率,可能是由于主动分泌过程。